EUS‐Guided Cyanoacrylate Injection With Balloon‐Compression Sclerotherapy Versus Band Ligation for Gastroesophageal Varices: A Randomized Trial
Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3375-3384
DOI: 10.1111/jgh.70715 ↗Abstract
ABSTRACT Background and Objectives Gastroesophageal varices (GOV) is a life‐threatening complication of portal hypertension. Endoscopic ultrasound–guided cyanoacrylate injection (EUS‐CYA) improves gastric variceal treatment, but the optimal strategy for concomitant esophageal varices (EV) remains unclear. We compared EUS‐CYA combined with balloon‐compression endoscopic injection sclerotherapy (bc‐EIS) versus EUS‐CYA combined with endoscopic variceal ligation (EVL). Methods Single‐center randomized controlled trial (July 2022–June 2025). Cirrhotic patients with GOV were assigned 1:1 to EUS‐CYA + bc‐EIS ( n = 62) or EUS‐CYA + EVL ( n = 62). All received EUS‐guided “sandwich technique” for gastric varices (GV). Then, bc‐EIS (polidocanol under balloon compression for 10 min) or EVL (spiral ligation) was performed for EV. The primary endpoint was combined eradication rate of both GV and EV at 6 months. Results GV final eradication: 100% in both groups. EV eradication: 100% in the bc‐EIS group versus 82.3% in the EVL group ( p < 0.001). Fewer sessions needed for bc‐EIS (1.4 ± 0.6 vs. 2.1 ± 1.1, p < 0.001). Rebleeding: 9.7% versus 21.0% ( p = 0.081). Independent rebleeding risk factors: esophageal variceal diameter > 10 mm (HR = 6.98) and prior bleeding (HR = 4.57). No significant differences in hemostasis (100% both), complications (14.5% vs. 17.7%), or recurrence (0 vs. 3.2%). No severe adverse events. Conclusion EUS‐CYA combined with bc‐EIS significantly improves esophageal variceal eradication and reduces treatment sessions compared with EUS‐CYA + EVL, with comparable safety. Trial Registration ChiCTR2000039974
EUVIMED